NAGE
Niagen Bioscience, Inc.
NASDAQ: NAGE · HEALTHCARE · BIOTECHNOLOGY
$4.76
-1.65% today
Updated 2026-04-29
Market cap
$381.18M
P/E ratio
23.80
P/S ratio
2.95x
EPS (TTM)
$0.20
Dividend yield
—
52W range
$4 – $15
Volume
1.2M
Niagen Bioscience, Inc. (NAGE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-38483.00 | $-1.92M | $-396172.00 | $-2.66M | $-4.10M | $-10.12M | $-3.91M | $-2.58M | $-2.11M | $-2.94M | $-9.80M | $-20.91M | $-20.44M | $-10.60M | $-24.16M | $-15.10M | $7.12M | $12.11M | $13.44M |
| Capital expenditures | $0.00 | $495807.00 | $184487.00 | $199136.00 | $176663.00 | $76565.00 | $226349.00 | $251740.00 | $647731.00 | $1.72M | $1.35M | $1.45M | $753000.00 | $142000.00 | $409000.00 | $334000.00 | $148000.00 | $163000.00 | $292000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $121185.00 | $205858.00 | $1.26M | $2.97M | $2.70M | $1.29M | $2.92M | $1.98M | $1.19M | $4.61M | $6.37M | $7.17M | $6.94M | $6.20M | $5.74M | $4.75M | $3.66M | $6.07M |
| Free cash flow | $-38483.00 | $-2.42M | $-580659.00 | $-2.86M | $-4.28M | $-10.20M | $-4.13M | $-2.83M | $-2.76M | $-4.66M | $-11.15M | $-22.36M | $-21.19M | $-10.74M | $-24.57M | $-15.43M | $6.97M | $11.95M | $13.14M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |